Hemodialysis Graft Mechanical Thrombolysis with Use of the Amplatz Thrombectomy Device: Histopathologic Evaluation of Extracted Myointimal Tissue

1999 ◽  
Vol 10 (3) ◽  
pp. 285-288 ◽  
Author(s):  
Stanley G. Cooper ◽  
Harold Gaetz ◽  
Constantinos T. Sofocleous ◽  
Israel Schur ◽  
Rajesh I. Patel
1998 ◽  
Vol 170 (5) ◽  
pp. 1177-1180 ◽  
Author(s):  
J Görich ◽  
N Rilinger ◽  
R Sokiranski ◽  
S Krämer ◽  
V Mickley ◽  
...  

2020 ◽  
pp. 026835552096688
Author(s):  
Orhan Rodoplu ◽  
Cenk Eray Yildiz ◽  
Didem Melis Oztas ◽  
Metin Onur Beyaz ◽  
Mustafa Ozer Ulukan ◽  
...  

Objective In this study, we aimed to evaluate the efficiency of rotational thrombectomy device in pharmaco-mechanical thrombolysis for symptomatic acute ilio-femoral deep vein thrombosis. Materials and methods Between August 2013 and May 2018,82 patients with acute deep vein thrombosis comprising the iliofemoral segment whom underwent Pharmaco-mechanical thrombolysis were evaluated retrospectively. The Cleaner thrombectomy device was used. The resolution of thrombi was examined and graded. Development of post-thrombotic syndrome was assessed with Villalta scores. Results 75 patients (91.4%) had complete thrombus resolution. Between 50–99% resolution was noted in 6 patients (7.4%) and in one (1.2%) case less than %50 thrombus resolution was obtained. Seventy-five patients (91%) of the cohort could be treated in a single session; 7 patients (8.6%) required reintervention(s). Although improved post-thrombotic syndrome rates were lower at the short term, Villalta scores gradually increased during follow up. Conclusions In conclusion, Pharmaco-mechanical thrombolysis with Cleaner thrombectomy device is a safe and beneficial method for the treatment of acute iliofemoral deep vein thrombosis. Long term follow up data of large volume multicenter studies are warranted.


2010 ◽  
Vol 58 (S 01) ◽  
Author(s):  
A Juraszek ◽  
G Bayer ◽  
T Dziodzio ◽  
J Holfeld ◽  
J Dumfarth ◽  
...  

2002 ◽  
Vol 9 (6) ◽  
pp. 917-921 ◽  
Author(s):  
Thomas Zeller ◽  
Ulrich Frank ◽  
Karlheinz Bürgelin ◽  
Lutz Sinn ◽  
Barbara Horn ◽  
...  

2021 ◽  
Vol 73 (3) ◽  
pp. 46-47
Author(s):  
Hunter M. Ray ◽  
Alejandro Pizano ◽  
Naveed U. Saqib ◽  
Stuart A. Harlin

2021 ◽  
Vol 77 (18) ◽  
pp. 1030
Author(s):  
Ahmad Tarek Chami ◽  
Tony Dong ◽  
Nour Tashtish ◽  
Haytham Mously ◽  
Mehdi Shishehbor ◽  
...  

2021 ◽  
pp. 1098612X2199144
Author(s):  
Edwina K Love ◽  
Nicole F Leibman ◽  
Randy Ringold ◽  
Kenneth Lamb

Objectives The aim of this study was to evaluate serum haptoglobin as a biomarker to differentiate between small-cell alimentary lymphoma and inflammatory bowel disease in cats. Methods Client-owned domestic cats with and without chronic gastrointestinal signs were enrolled in the study. Serum was collected from each patient and serum haptoglobin levels were measured using ELISA. In cats with gastrointestinal signs, histopathologic evaluation of endoscopic biopsies harvested from the intestinal tract was used to separate them into inflammatory bowel disease and small-cell lymphoma cohorts. Serum haptoglobin levels were statistically analyzed and compared among the three groups: healthy cats; cats with inflammatory bowel disease; and cats with small-cell alimentary lymphoma. Results Sixty-two cats were enrolled in the study, including 20 clinically normal cats, 14 cats with small-cell alimentary lymphoma and 28 cats with inflammatory bowel disease. The mean ± SD serum haptoglobin was 73.2 ± 39.1 mg/dl in normal cats, 115.3 ± 72.8 mg/dl in cats with inflammatory bowel disease and 133.1 ± 86.1 mg/dl in cats with small-cell alimentary lymphoma. Cats with inflammatory bowel disease and lymphoma had significantly higher serum haptoglobin than controls, with P values of 0.0382 and 0.0138, respectively. There was no statistical difference between the inflammatory bowel disease and lymphoma cohorts ( P = 0.4235). For every one unit increase in serum haptoglobin, the odds of gastrointestinal inflammatory disease (inflammatory bowel disease or small-cell alimentary lymphoma) increased by 1.41% ( P = 0.0165). Conclusions and relevance Serum haptoglobin is a useful biomarker for distinguishing between normal cats and those with gastrointestinal inflammatory disease, but it could not significantly differentiate between inflammatory bowel disease and lymphoma. Additional studies may be beneficial in determining the prognostic significance of serum haptoglobin as it may relate to the severity of gastrointestinal inflammation.


Author(s):  
Nihan Yesilkaya ◽  
Tahsin Murat Tellioglu ◽  
Fulya Cakalagaoglu Unay ◽  
Hasan İner ◽  
Yuksel Besir ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document